Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Critical issues in digestive diseases.

Deborah D Proctor1

  • 1Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, 1080 LMP, New Haven, CT 06520, USA. deborah.proctor@yale.edu

Clinics in Chest Medicine
|January 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence, patient characteristics, and outcomes of high-dose upadacitinib in inflammatory bowel disease.

Therapeutic advances in gastroenterology·2026
Same author

Concise Commentary: Twelve Steps on the Path to Improving Training Programs-Recruiting GI Fellows in 2024 and Beyond.

Digestive diseases and sciences·2024
Same author

Longer Colonoscopy Withdrawal Time Is Associated With the Detection of Visible Dysplasia in Patients With Inflammatory Bowel Disease.

Crohn's & colitis 360·2024
Same author

Early Flexible Sigmoidoscopy Improves Clinical Outcomes in Acute Severe Ulcerative Colitis.

Crohn's & colitis 360·2023
Same author

Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease.

European journal of gastroenterology & hepatology·2023
Same author

Impact of thiopurine dose in anti-tumor necrosis factor combination therapy on outcomes in inflammatory bowel disease.

Annals of gastroenterology·2023
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

This article covers critical care topics including gastrointestinal (GI) bleeding and acalculous cholecystitis. Early diagnosis and management are key for these ICU conditions, with surgery rarely needed for GI bleeds.

Area of Science:

  • Critical Care Medicine
  • Gastroenterology
  • Surgical Critical Care

Background:

  • Common intensive care unit (ICU) conditions include acute gastrointestinal (GI) bleeding, acute pancreatitis, and acalculous cholecystitis.
  • Acute GI bleeding is often clinically apparent and manageable with interventional radiology, minimizing surgical intervention.
  • Acalculous cholecystitis presents diagnostic challenges, necessitating a high index of suspicion in critically ill patients.

Purpose of the Study:

  • To review the diagnosis and management strategies for acute GI bleeding.
  • To discuss prophylaxis measures for GI bleeding.
  • To outline the diagnostic and management approaches for acute pancreatitis and acalculous cholecystitis in the ICU.

Main Methods:

  • Literature review and synthesis of current clinical practices.

Related Experiment Videos

  • Discussion of diagnostic criteria and imaging modalities.
  • Overview of therapeutic interventions, including medical and radiological options.

    • Main Results:

    • Acute GI bleeding is frequently diagnosed and treated non-surgically using advanced techniques.
    • Prophylaxis strategies are essential for preventing GI bleeding in at-risk ICU patients.
    • Acalculous cholecystitis requires heightened clinical vigilance due to diagnostic difficulties.

    Conclusions:

    • Effective management of acute GI bleeding relies on prompt diagnosis and interventional radiology.
    • Prophylaxis is crucial for preventing GI bleeding in critically ill patients.
    • Early recognition and suspicion are vital for diagnosing acalculous cholecystitis in the ICU setting.